Get the Stockscreener App
21.40
1.81%
-0.37
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $21.40, with a volume of 6.30M.
It is down -1.81% in the last 24 hours and up +4.01% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$21.77
Open:
$21.74
24h Volume:
6.30M
Relative Volume:
0.74
Market Cap:
$11.00B
Revenue:
$10.89B
Net Income/Loss:
$-241.00M
P/E Ratio:
-80.57
EPS:
-0.2656
Net Cash Flow:
$340.00M
1W Performance:
+6.50%
1M Performance:
+4.01%
6M Performance:
-5.00%
1Y Performance:
-30.62%
1-Day Range:
$21.30
$21.87
1-Week Range:
$19.55
$21.93
52-Week Range:
$17.40
$37.74
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, MDLN, RMD, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
21.39 | 11.19B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
490.22 | 169.16B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
206.81 | 58.84B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
MDLN
Medline Inc
|
47.46 | 38.45B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
269.80 | 38.90B | 5.40B | 1.49B | 1.78B | 10.12 |
|
ALC
Alcon Inc
|
78.31 | 38.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Argus | Buy → Hold |
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Baxter Shares Face Pivotal Moment Ahead of Earnings Release - AD HOC NEWS
Baxter eliminates 3% of Marion facility's workforce, cites post-Helene market conditions - WLOS
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Baxter International: Steady Pulse, Cautious Optimism As The Stock Grinds Higher - AD HOC NEWS
How Recent Moves Are Rewriting The Story For Baxter International (BAX) - Yahoo Finance
US Market Wrap: Can Baxter International Inc deliver alphaJuly 2025 Trends & Consistent Profit Trading Strategies - baoquankhu1.vn
Here’s What Hit Baxter (BAX) in Q4 - Insider Monkey
Why Hospitals Are Phasing Out a Popular Operating Room Anesthetic - Bloomberg
[Latest] Global Advanced Wound Closure Market Size/Share Worth USD 32.54 Billion by 2035 at a 6.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Niranjan Damle Elevated to Senior Director – Global Portfolio & Marketing at Baxter - CXO Digitalpulse
The Bull Case For Baxter International (BAX) Could Change Following Hurricane Hit And Guidance Cut - Sahm
Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings - Quantisnow
Does Baxter International (BAX) Offer Opportunity After Prolonged Share Price Weakness? - Yahoo Finance
Greenhaven Associates Inc. Takes Position in Baxter International Inc. $BAX - MarketBeat
The Truth About Baxter International Inc.: Is This ‘Boring’ Stock About To Go Viral? - AD HOC NEWS
Are Wall Street analysts predicting Baxter International stock will climb or sink? - MSN
Baxter Stock Performance & 2025 Outlook: Earnings, Analyst Ratings, Price TargetNews and Statistics - IndexBox
Are financial experts on Wall Street forecasting that Baxter International's stock will rise or fall? - Bitget
Are Wall Street Analysts Predicting Baxter International Stock Will Climb or Sink? - Barchart.com
Reasons to Retain Baxter International Stock in Your Portfolio Now - Prime Publishers, Inc.
Jobs Data: Is Baxter International Inc in a long term uptrend2025 Dividend Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
Baxter’s Strategic Pivot Faces Key Test with Upcoming Earnings - AD HOC NEWS
Baxter declares $0.01 dividend - MSN
Baxter International Inc. $BAX Shares Purchased by Cooke & Bieler LP - MarketBeat
Stoneridge Investment Partners LLC Buys Shares of 93,458 Baxter International Inc. $BAX - MarketBeat
Assessing Baxter International (BAX) Valuation After Dynamo Series Stretcher Launch At J.P. Morgan Healthcare Conference - Sahm
Baxter International Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Baxter International Inc. (NYSE:BAX) Receives Consensus Rating of "Reduce" from Analysts - MarketBeat
Baxter International Inc. Stock: Hidden Health-Care Giant or Total Snooze Buy? - AD HOC NEWS
Baxter International (NYSE:BAX) Stock Rating Lowered by Zacks Research - MarketBeat
Baxter International Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains - 富途资讯
FOMO Trade: Is Baxter International Inc stock risky to hold nowJuly 2025 Fed Impact & Daily Price Action Insights - baoquankhu1.vn
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors - marketscreener.com
What you need to know ahead of Baxter International's earnings release - MSN
Aug Chart Watch: Is Baxter International Inc in a long term uptrend2025 Valuation Update & Safe Entry Zone Tips - baoquankhu1.vn
Did Baxter’s New Dynamo Smart Stretcher Launch Just Shift Baxter International's (BAX) Investment Narrative? - Yahoo Finance
Baxter's Room Temperature HEMOPATCH Sealing Hemostat Gains Momentum in Australia and New Zealand - PR Newswire
Baxter International: Transition Year With No Immediate Catalysts (NYSE:BAX) - Seeking Alpha
Assessing Baxter International (BAX) Valuation After Mixed Short And Long Term Shareholder Returns - Yahoo Finance
How Recent Analyst Shifts Are Rewriting The Baxter International (BAX) Investment Story - Yahoo Finance
Big Picture: Will Baxter International Inc be affected by tariffsJuly 2025 Update & High Conviction Trade Alerts - baoquankhu1.vn
Sentiment Review: Is SEAT a top pick in the sectorQuarterly Market Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Baxter International Stock: Quiet Turnaround Play Or Value Trap In Healthcare Tech? - AD HOC NEWS
What To Be Aware Of Before Baxter International Announces Its Earnings - Bitget
Baxter International Inc. (BAX) Stock Analysis: Exploring a 15% Potential Upside Amidst Strategic Global Operations - directorstalkinterviews.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What You Need To Know Ahead of Baxter International's Earnings Release - Barchart.com
Sodium Chloride Injections Market, Global Forecast 2026-2032 - GlobeNewswire Inc.
The Bottom Fishing ClubBaxter: Defensive Pick, Restructuring And Paying Down Debt (BAX) - Seeking Alpha
Baxter International (NYSE:BAX) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Baxter International (BAX) Faces Weak EPS Revision Grades - GuruFocus
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.69%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):